Longitudinal induced IL-2 mRNA monitoring in renal transplant patients immunosuppressed with cyclosporine and in unmodified canine renal transplant rejection

Human Immunology

Volumn 45, Issue 1, 1996, Pages 1-12

  Zucker, Carol ^a   Zucker, Keith ^a   Asthana, Deshratn ^a   Carreno, Manuel ^a   Viciana, Ana L ^a   Ruiz, Philip ^a   Esquenazi, Violet ^a   Nery, Jose ^a   Burke, George ^a   Miller, Joshua ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CYCLOSPORIN A; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; MESSENGER RNA; PHYTOHEMAGGLUTININ; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOG; GRAFT REJECTION; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ASSAY; RECEPTOR DOWN REGULATION; REPRODUCIBILITY; RNA ANALYSIS;

EID: 0029968013     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/0198-8859(95)00154-9     Document Type: Article

References (45)

1. Yoshimira N, Kahan BP: Pharmacodynamic assessment of the in vivo cyclosporin effect in interleukin-2 production by lymphocytes in kidney transplant recipients. Transplantation 40:661, 1985.
2. Schreiber S, Crabtree G: The mechanism of action of cyclosporin A and FK506. Immunol Today 13:136, 1992.
3. Liu J: FK506 and cyclosporin: molecular probes for studying intracellular signal transduction. Trends Pharm Sci 14:182, 1993.
4. Wiederrecht G, Lam E, Hung S, Martin M, Sigal N: The mechanism of action of FK-506 and cyclosporin A. Ann NY Acad Sci 696:9, 1993.
5. Yoshimura N, Oka T, Clark SC, Kahan BD: The inhibition of interleukin 2 (IL-2) gene expression at the level of messenger RNA by in vivo cyclosporin treatment in kidney transplant recipients. Transplant Proc 19:3510, 1987.
6. Dallman MJ, Porter ACG, Larsen CP, Morris PJ: Lymphokine production in allografts, analysis of RNA by Northern blotting. Transplant Proc 21:296, 1989.
7. McKenna RM, Rush DN, Akkestad-Legare PB, Jeffery JR: Interleukin 2, interferon, and lymphotoxin in renal transplant recipients. Transplantation 45:76, 1988.
8. Koutouby R, Zucker C, Zucker K, Burke G, Nery J, Roth D, Esquenazi V, Miller J: Molecular monitoring of the immunosuppressive effects of cyclosporine in renal transplant patients using a quantitative polymerase chain reaction. Hum Immunol 36:227, 1993.
9. Bynn BC, Li JJ, Sninsky J, Poiesz BJ: Detection of HIV-1 RNA sequences by in vitro DNA amplification. Nucleic Acids Res 16:4165, 1988.
10. Kawamura A (ed): Fluorescent Antibody Techniques, 2nd ed. Baltimore, University Park Press, 1977.
11. Solez K, Alexsen RA, Hallgrimur B, Burdick JF, Cohen AH, Colvin RB, Croker BP, Droz D, Dunnill MS, Halloran PF, Häyry P, Jennette JC, Keown PA, Marcussen N, Mihatsch MJ, Morozumi K, Myers BD, Nast CC, Olsen S, Racusen LC, Ramos EL, Rosen S, Sachs DH, Salomon DR, San Fillipo F, Verani R, Von Willebrand E, Yamaguchi Y: International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int 44:411, 1993.
12. Carreno M, Esquenazi V, Olson L, Fuller L, Alejandro R, Milgrom M, Miller J: Comparison of two monoclonal antibodies affecting canine transplantation reactions. Transplant Proc 19:612, 1987.
13. Siebert PD, Larrick JW: PCR MIMICS: Competitive DNA fragments for use as internal standards in quantitative PCR. Biotechniques 14:244, 1993.
14. Gern J, Jayman J, Goldberg L, Murphy P, Lederman H: Temperature is a powerful promoter of interleukin 2 transcription. Cytokine 3:389, 1991.
15. Cornaby A, Simpson M, Vann Rice R, Dempsey R, Madras P, Monaco A: Interleukin-2 production in plasma and urine, plasma interleukin-2 receptor levels, and urine cytology as a means of monitoring renal allograft recipients. Transplant Proc 20:108, 1988.
16. Albert FW, Schmidt U, Seyfert UT, Würmell W, Gümbel W: Interleukin-2 measurements in peripheral blood after kidney transplantation. Transplant Proc 22:1852, 1990.
17. Katila H, Cantell K, Appelberg B, Rimón R: Is there a seasonal variation in the interferon-producing capacity of healthy subjects? J Interferon Res 13:233, 1993.
18. Gillis S, Watson J, Mochizuki D: Biochemical characterization of interleukin-2 (T cell growth factor). In Fathman C, Fitch F (eds): Isolation, Characterization, and Utilization of T Lymphocyte Clones. New York, Academic Press, 1982.
19. Grimm E, Rosenberg S: Production and properties of human IL-2. In Fathman C, Fitch F (eds): Isolation, Characterization, and Utilization of T Lymphocyte Clones. New York, Academic Press, 1982.
20. Sjöberg O, Tötterman T: Variations in inhibition by cyclosporin A of the proliferative response, using different individuals and T cell stimulators. Transplant Proc 18:40, 1986.
21. Martinez O, Villanueva J, Lake J, Roberts J, Ascher N, Krams S: IL-2 and IL-5 gene expression in response to alloantigen in liver allograft recipients and in vitro. Transplantation 55:1159, 1993.
22. Riesbeck K, Sigvardsson M, Leanderson T, Forsgren A: Superinduction of cytokine gene transcription by ciprofloxacin. J Immunol 153:343, 1994.
23. Riesbeck K, Gullberg M, Forsgren A: Evidence that the antibiotic ciprofloxacin counteracts cyclosporin-dependent suppression of cytokine production. Transplantation 57:267, 1994.
24. Jordan ML, Shapiro R, Vivas CA, Scantlebury VP, Darras FS, Carrieri G, McCauley J, Demetris AJ, Randhawa P, Jensen C, Hakala TR, Fung JJ, Starzl TE: FK506 salvage of renal allografts with ongoing rejection failing cyclosporin immunosuppression. Transplant Proc 25:638, 1993.
25. Johnson C, Chaharmohal A, Buchmann E, Rosa A, Adams M: Plasma IL-2 levels and diagnosis of renal transplant rejection. Transplant Proc 22:1849, 1990.
26. Tice D, Heintz S, Scruggs B, Hubbell C, Szmalc F: Immune monitoring: does the reality fulfill the promise? Transplant Proc 25:2654, 1993.
27. Miller J, Hattler BG, Davis M, Johnson MC: Cellular and humoral factors governing canine mixed lymphocyte cultures after renal transplantation, I. Antibody. Transplantation 12:65, 1971.
28. Fuggle SV, Sanderson JB, Gray DWR, Richardson A, Morris PJ: Variation in expression of endothelial adhesion molecules in pretransplant and transplanted kidneys; correlation with intragraft events. Transplantation 55:117, 1993.
29. Brockmeyer C, Ulbrecht M, Schendel DJ, Weiss EH, Hillebrand G, Burkhardt K, Land W, Gokel MJ, Riethmüller, Feucht HE: Distribution of cell adhesion molecules (ICAM-1, V-CAM, ELAM-1) in renal tissue during allograft rejection. Transplantation 55:610, 1993.
30. Hattler BG, Miller J, Johnson MC: Cellular and humoral factors governing canine mixed lymphocyte cultures after renal transplantation. II. Cellular. Transplantation 14:47, 1972.
31. Dallman M, Roake J, Hughes D, Toogood G, Morris P: Sequential analysis of IL-2 gene transcription in renal transplants. Transplantation 53:683, 1992.
32. Yard B, Kooymans-Couthino M, Paape M, Bruijn J: Analysis of cytokine production by graft-infiltrating cells isolated from rejecting renal allografts. Transplantation 57:153, 1994.
33. Caput D, Beutler B, Hartog K, Thayer R, Brown-Shimer S, Cerami A: Identification of a common nucleotide sequence on the 3′-untranslated region of mRNA molecules specifying inflammatory mediators. Proc Natl Acad Sci USA 83:1670, 1986.
34. Shaw G, Kamen RA: Conserved AU sequence from the 3′-untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46:659, 1986.
35. Dallman M, Shiho O, Page T, Wood K, Morris P: Peripheral tolerance to alloantigen results from altered regulation of the interleukin 2 pathway. J Exp Med 173:79, 1991.
36. Dallman M, Larsen C, Morris P: Cytokine gene transcription in vascularized organ grafts: analysis using semiquantitative polymerase chain reaction. J Exp Med 174: 493, 1991.
37. Malefyt RdW, Abrams J, Bennett B, Figdor CG, de Vries JE: Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174:1209, 1991.
38. Malefyt RdW, Haanen J, Spits H, Roncarolo M-G, te Velde A, Figdor C, Johnson K, Kastelein R, Yssel H, de Vries JE: Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 174:915, 1991.
39. Mosmann TR: Properties and functions of interleukin-10. Adv Immunol 56:1, 1994.
40. Charlton B, Auchincloss Jr H, Fathman CG: Mechanisms of transplant tolerance. Annu Rev Immunol 12:707, 1994.
41. Chen N, Field EH: Enhanced type 2 and diminished type 1 cytokines in neonatal tolerance. Transplantation 59: 933, 1995.
42. Manetti R, Annunziato F, Biagiotti R, Guidizi MG, Piccinni MP, Giannarini L, Sampognaro S, Parronchi P, Vinante F, Pizzolo G, Maggi E, Romagnani S: CD30 expression by CD8+ T cells producing type 2 helper cytokines. Evidence for large numbers of CD8+CD30+ T cell clones in human immunodeficiency virus infection. J Exp Med 180:2407, 1994.
43. Del Prete G, De Carli M, Almerigogna F, Daniel CK, D'Elios MM, Zancuoghi G, Vinante F, Pizzolo G, Romagnani S: Preferential expression of CD30 by human CD4+ T cells producing Th2-type cytokines. FASEBJ 9:81, 1995.
44. Brabletz T, Pfeuffer I, Schorr E, Siebert F, Wirth T, Serfling E: Transforming growth factor β and cyclosporin A inhibit the inducible activity of the interleukin-2 gene in T cells through a noncanonical octamer-binding site. Mol Cell Bio 13:1155, 1993.
45. Miller J, Esquenazi V, Fuller L, Zucker K, Fernandez J, Burke G, Nery J: The immunologic response to allografts: acute rejection. Clin Transplant 5:47, 1991.